Hematological oncology · 2019
A case report of systemic mastocytosis associated with multiple hematologic non-mast cell lineage diseases.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Grifoni Federica Irene, Sciumè Mariarita, Pravettoni Valerio, Ulivieri Fabio Massimo, Muratori Simona, Fracchiolla Nicola Stefano, Tagliaferri Elena, Gianelli Umberto, Migliorini Anna Chiara, Cro Lilla, Pacilli Annalisa, Mannelli Francesco, Baldini Luca
Аннотация
Systemic mastocytosis (SM) is a hematological malignancy characterized by extracutaneous infiltration by atypical mast cells. Together with indolent SM, aggressive SM, and mast cell leukemia, the World Health Organization (WHO) recognizes another major disease subgroup: SM with an associated hematological neoplasm, which is characterized by the presence of a concurrent neoplasm, more commonly, a chronic myelomonocytic leukemia. While KIT D816V is commonly regarded as the driver mutation, the clinical presentation of SM is extremely varied. Treatment of SM might not be simple, but now more specific therapies tailored toward prognostic subgroups of patients have been developed. Here, we report a detailed description of clinical management and biological features of a systemic mastocytocis case associated with multiple hematologic non-mast cell lineage diseases.